|
KPNA3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.5432000000668E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.11449999998337E-06 |
| Normal-vs-Stage2 |
9.93510000000253E-05 |
| Normal-vs-Stage3 |
1.98219999969496E-07 |
| Normal-vs-Stage4 |
3.23600002349878E-09 |
| Stage1-vs-Stage2 |
5.733000E-01 |
| Stage1-vs-Stage3 |
1.223180E-01 |
| Stage1-vs-Stage4 |
4.421400E-03 |
| Stage2-vs-Stage3 |
6.052200E-01 |
| Stage2-vs-Stage4 |
1.295550E-01 |
| Stage3-vs-Stage4 |
2.091600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.58219999721621E-08 |
| Normal-vs-AfricanAmerican |
1.978580E-03 |
| Normal-vs-Asian |
3.93770000051141E-07 |
| Caucasian-vs-AfricanAmerican |
7.699200E-01 |
| Caucasian-vs-Asian |
3.641400E-01 |
| AfricanAmerican-vs-Asian |
3.638400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.9655999999868E-06 |
| Normal-vs-Female |
4.52970000397457E-08 |
| Male-vs-Female |
9.363400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.82390000000355E-05 |
| Normal-vs-Age(41-60Yrs) |
5.50070000659986E-09 |
| Normal-vs-Age(61-80Yrs) |
2.82190000033822E-07 |
| Normal-vs-Age(81-100Yrs) |
2.630000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.963810E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.571600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.998800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.236000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.440800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.124600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.020200E-01 |
| Classical-VS-Follicular |
9.985200E-01 |
| Classical-VS-Other |
4.856800E-01 |
| Classical-VS-Normal |
1.48040000036431E-07 |
| Tall-VS-Follicular |
7.539600E-01 |
| Tall-VS-Other |
4.446000E-01 |
| Tall-VS-Normal |
2.632100E-04 |
| Follicular-VS-Other |
5.531200E-01 |
| Follicular-VS-Normal |
6.06739999999828E-05 |
| Other-VS-Normal |
1.961020E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.64199999994364E-07 |
| Normal-vs-N1 |
3.82770000140198E-08 |
| N0-vs-N1 |
1.577230E-01 |
|
|
